Supreme Court: Single Insolvency Petition Maintainable Against Linked Corporate Entities || Supreme Court: Disputes are Not Arbitrable When the Arbitration Agreement is Alleged to be Forged || Supreme Court: Temple Trust Does Not Qualify as an ‘Industry’ under the Industrial Disputes Act || Delhi HC: Unmarried Granddaughter’s Limited Estate Can Become Absolute if Pre-Existing Right || MP High Court: Labour Laws are Beneficial, and Hyper-Technical Limitation Views Must be Avoided || Calcutta HC: Supplementary Chargesheet Filed Late in NDPS Trial is Valid if Based on Fresh Evidence || Delhi High Court: Co-Accused’s Abscondence Can Be a Relevant Factor in Granting NDPS Bail || P &H HC: Unfavourable Orders Cannot Justify Trial Transfer; Courts Must Prevent Forum Hunting || SC: UGC Regulations Override State Law on Forming Search Committees For University VC Appointments || SC: State Cannot Deny Regularisation to Long-Serving Contract Staff Appointed Through Due Process

Drugs and Cosmetics (Amendment) Bill, 2015 - (30 Nov 2015)

Miscellaneous

The Drugs and Cosmetics (Amendment) Bill, 2015, set to be introduced in the Parliament’s Winter Session, 2015, proposes much needed updates to the Drugs and Cosmetics Act, 1940. The Bill, 2015 broadens the scope of the government’s powers and introduces checks and balances in the manufacture, import, distribution and sale of drugs and cosmetics in India. Clinical trials are set to be overseen by the Ethics Committee, constituted under the Bill. The Committee will also have powers to audit clinical trials and make site visits to ensure safety and well being of participants. Greater regulation and oversight, stricter punishments and vigilance outline the proactive stance the Bill proposes for the government.

Tags : DRUG AND COSMETICS BILL 2015 ETHICS COMMITTEE

Share :